Abstract
Cystatin C, an inhibitor of cysteine proteases, colocalizes with amyloid β (Aβ) in parenchymal and vascular amyloid deposits in brains of Alzheimer’s disease (AD) patients, suggesting that cystatin C has a role in AD. Cystatin C also colocalizes with β amyloid precursor protein (βAPP) in transfected cultured cells. In vitro analysis of the association between the two proteins revealed that binding of cystatin C to full-length βAPP does not affect the level of Aβ secretion. Here we studied the effect of in vivo overexpression of cystatin C on the levels of endogenous brain Aβ. We have generated lines of transgenic mice expressing either wild-type human cystatin C or the Leu68Gln variant that forms amyloid deposits in the cerebral vessels of Icelandic patients with hereditary cerebral hemorrhage, under control sequences of the human cystatin C gene. Western blot analysis of brain homogenates was used to select lines of mice expressing various levels of the transgene. Analysis of Aβ40 and Aβ42 concentrations in the brain showed no difference between transgenic mice and their nontransgenic littermates. Thus, in vivo overexpression of human cystatin C does not affect Aβ levels in mice that do not deposit Aβ.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett A. J., Davies M. E., and Grubb A. O. (1984) The place of human γ trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem. Biophys. Res. Commun. 120, 631–636.
Beyer K., Lao J. I., Gomez M., Riutort N., Latorre P., Mate J. L., and Ariza A. (2001) Alzheimer’s disease and the cystatin C gene polymorphism: an association study. Neurosci. Lett. 315, 17–20.
Bobek L. A. and Levine M. J. (1992) Cystatins-inhibitors of cysteine proteinases. Crit. Rev. Oral Biol. Med. 3, 307–332.
Calero M., Pawlik M., Soto C., Castaño E. M., Sigurdsson E., Kumar A., et al. (2001) Distinct properties of wildtype and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J. Neurochem. 77, 628–637.
Cohen D. H., Feiner H., Jensson O., and Frangione B. (1983) Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastrenteropancreatic neuroendocrine protein, γtrace. J. Exp. Med. 158, 623–628.
Crawford F. C., Freeman M. J., Schinka J. A., Abdullah L. I., Gold M., Hartman R., et al. (2000) A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease. Neurology 55, 763–768.
Dodel R. C., Du Y., Depboylu C., Kurz A., Eastwood B., Farlow M., et al. (2002) A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD. Neurology 58, 664.
Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., et al. (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122–1124.
Esnard A., Esnard F., and Gauthier F. (1988) Purification of the cystatin C-like inhibitors from urine of nephropathic rats. Biol. Chem. Hoppe-Seyler. 369 (Suppl.), 219–222.
Esnard F., Esnard A., Faucher D., Capony J. P., Derancourt J., Brillard M., and Gauthier F. (1990) Rat cystatin C: the complete amino acid sequence reveals a site for N-glycosylation. Biol. Chem. Hoppe-Seyler. 371 (Suppl.), 161–166.
Finckh U., von Der Kammer H., Velden J., Michel T., Andresen B., Deng A., et al. (2000) Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch. Neurol. 57, 1579–1583.
Ghiso J., Jensson O., and Frangione B. (1986) Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis is a variant of γ trace basic protein (cystatin C). Proc. Natl. Acad. Sci. USA 83, 2974–2978.
Glenner G. G. and Wong C. W. (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890.
Gudmundsson G., Hallgrimsson J., Jonasson T. A., and Bjarnason O. (1972) Hereditary cerebral haemorrhage with amyloidosis. Brain 95, 387–404.
Haan J., Maat-Schieman M. L. C., van Duinen S. G., Jensson O., Thorsteinsson L., and Roos R. A. C. (1994) Co-localization of β/ A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis. Acta Neurol. Scand. 89, 367–371.
Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., et al. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325.
Hochwald G. M., Pepe A. J., and Thorbecke G. J. (1967) Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of γ trace and β trace proteins. Proc. Soc. Exp. Med. 124, 961–966.
Huh C. G., Hakansson K., Nathanson C. M., Thorgeirsson U. P., Jonsson N., Grubb A., et al. (1999) Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol. Pathol. 52, 332–340.
Itoh Y., Yamada M., Hayakawa M., Otomo E., and Miyatake T. (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J. Neurol. Sci. 116, 135–141.
Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., et al. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736.
Levy E., Lopez-Otin C., Ghiso J., Geltner D., and Frangione B. (1989) Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J. Exp. Med. 169, 1771–1778.
Levy E., Sastre M., Kumar A., Gallo G., Piccardo M. D., Ghetti B., and Tagliavini F. (2001) Codeposition of cystatin C with amyloid-β protein in the brain of Alzheimer’s disease patients. J. Neuropathol. Exp. Neurol. 60, 94–104.
Maruyama K., Ikeda S., Ishihara T., Allsop D., and Yanagisawa N. (1990) Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to β protein and cystatin C. Stroke 21, 397–403.
Maruyama H., Izumi Y., Oda M., Torii T., Morino H., Toji H., et al. (2001) Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease. Neurology 57, 337–339.
Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245–4249.
Olafsson I., Thorsteinsson L., and Jensson O. (1996) The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Brain Pathol. 6, 121–126.
Olson J. M., Goddard K. A., and Dudek D. M. (2002) A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am. J. Hum. Genet. 71, 154–161.
Palm D. E., Knuckey N. W., Primiano M. J., Spangenberger A. G., and Johanson C. E. (1995) Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res. 691, 1–8.
Roks G., Cruts M., Slooter A. J., Dermaut B., Hofman A., Van Broeckhoven C., and Van Duijn C. M. (2001) The cystatin C polymorphism is not associated with early onset Alzheimer’s disease. Neurology 57, 366–367.
Rozmahel R., Huang J., Chen F., Liang Y., Nguyen V., Ikeda M., et al. (2002) Normal brain development in PS1 hypomorphic mice with markedly reduced γ-secretase cleavage of βAPP. Neurobiol. Aging 23, 187–194.
Sastre M., Calero M., Pawlik M., Mathews P. M., Kumar A., Danilov V., et al. (2004) Binding of cystatin C to Alzheimer’s amyloid β inhibits amyloid fibril formation. Neurobiol. Aging, in press.
Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., et al. (1992) Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids. Nature 359, 325–327.
Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., et al. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126–129.
Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that β-amyloid protein in Alzheimer’s disease is not derived by normal processing. Science 248, 492–495.
Steinhoff T., Moritz E., Wollmer M. A., Mohajeri M. H., Kins S., and Nitsch R. M. (2001) Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques. Neurobiol. Dis. 8, 647–654.
Taupin P., Ray J., Fischer W. H., Suhr S. T., Hakansson K., Grubb A., and Gage F. H. (2000) FGF-2-Responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 28, 385–397.
Turk V. and Bode W. (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213–219.
Vattemi G., Engel W. K., McFerrin J., and Askanas V. (2003) Cystatin C colocalizes with amyloid-β and coimmunoprecipitates with amyloid β precursor protein in sporadic inclusion-body myositis muscles. J. Neurochem. 85, 1539–1546.
Vinters H. V., Nishimura G. S., Secor D. L., and Pardridge W. M. (1990) Immunoreactive A4 and γ trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer’s disease. Am. J. Pathol. 137, 233–240.
Wei L., Walker L. C., and Levy E. (1996) Cystatin C: Icelandic-like mutation in an animal model of cerebrovascular β amyloidosis. Stroke 27, 2080–2085.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pawlik, M., Sastre, M., Calero, M. et al. Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid β peptide. J Mol Neurosci 22, 13–18 (2004). https://doi.org/10.1385/JMN:22:1-2:13
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:22:1-2:13